Plenty of evidences have suggested that NF-κB activation and JAK signaling pathway are involved in the occurrence and progression of cancers through mediating inflammatory response and immune response as well as cell proliferation, apoptosis, and metastasis [31, 32]. Here, NFKB1 is linked to cancer.